Ledger.Open graph →
SEC Form D · filed April 2, 2025

ImmuneBridge Inc

Offering
$7.1M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Dylan A. Morris · New York, NYDirectorAlicia A. Jackson · San Francisco, CADirectorOmri A. Amirav-Drory · San Francisco, CADirectorBijan H. Pajoohi · ROCKLIN, CADirectorRobert J. Hugin · New York, NYDirectorNadiya A. Ishnazarova · Amsterdam, P7DirectorStuart A. Jacobson · San Francisco, CAExec · DirectorThomas A. Farrell · San Francisco, CADirectorRachid Sigelmassi · Frederick, MDDirectorMark P. Sealy · Irving, TXDirectorNadiya A. Ishnazarova · Amsterdam, P7DirectorOmri A. Amirav-Drory · San Francisco, CADirectorStuart A. Jacobson · San Francisco, CAExec · DirectorThomas A. Farrell · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗